Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects

NCT04422600 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT04422600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04422600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects
Lead sponsor
University of Arkansas
Phase
Observational
Overall status
Completed
Start date
February 26, 2020
Completion date
August 1, 2023
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal exposure timing unspecified